Joseph Drabick, MD - Penn State Cancer Institute
Researcher Profile
Joseph Drabick, MD
Professor and Rose Dunlap Division Chief Chair in Hematology/Oncology, Department of Medicine
Division of Hematology and Oncology
Division of Hematology and Oncology
Scientific Program:Next-Generation Therapies
Disease Teams:
Cancer Institute, Brain and Central Nervous System Cancer Team
Cancer Institute, Genitourinary Cancer Team
Cancer Institute, Immunotherapy Team
Cancer Institute, Melanoma and Skin Cancer Team
Cancer Institute, Sarcoma Cancer Team
Cancer Institute, Genitourinary Cancer Team
Cancer Institute, Immunotherapy Team
Cancer Institute, Melanoma and Skin Cancer Team
Cancer Institute, Sarcoma Cancer Team
Clinical Trials
General Protocol for the Acquisition of Whole Blood for the Detection and Characterization of Circulating Tumor Cells and/or Tumor Specific Immunity/Immune Cell Activation for any Malignancy at any Stage of Disease
Melanoma and Skin Cancer Clinical Database
A Retrospective Evaluation to Understand how â-adrenergic Antagonism Impacts the Progression of Melanoma and the Efficacy of Standard Treatments Intended to Eliminate the Cancer
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease (CIRCULATE-US) (NRG-GI008)
A Pragmatic Randomized Phase III Trial Evaluating Total Ablative Therapy for Patients With Limited Metastatic Colorectal Cancer: Evaluating Radiation, Ablation, and Surgery (ERASur) A022101
Recent Publications
2025
Bhanja, D, Zhu, J, Wilding, H, Benavides-Vasquez, J, de Macedo Filho, L, Ozair, A, Moeckel, C, Badani, A, Hong, J, Sivik, J, Drabick, JJ, Pameijer, CR, Margolin, K, Ahluwalia, M & Mansouri, A 2025, 'A Population-Level Real-World Analysis and Single-Center Validation of Melanoma Brain Metastasis Epidemiology following Dual-Agent Immunotherapy', Clinical Cancer Research, vol. 31, no. 15, pp. 3276-3284. https://doi.org/10.1158/1078-0432.CCR-24-2681
Lü, J, Jiang, C, Drabick, JJ, Joshi, M & Perimbeti, S 2025, 'Angelica gigas Nakai (Korean Dang-gui) Root Alcoholic Extracts in Health Promotion and Disease Therapy – active Phytochemicals and In Vivo Molecular Targets', Pharmaceutical Research, vol. 42, no. 1, pp. 25-47. https://doi.org/10.1007/s11095-024-03809-9
2024
Pu, JJ, Berger, KN, Zheng, C, Do, N, Claxton, DF, Ehmann, WC, Drabick, JJ, Li, H, Loughran, TP & Epner, EM 2024, 'A phase I study using bortezomib (Velcade), cladribine, and rituximab in treating patients over 50 years old with mantle cell lymphoma', Frontiers in Oncology, vol. 14, 1449401. https://doi.org/10.3389/fonc.2024.1449401
Pu, JJ, Drabick, JJ & Prockop, SE 2024, 'Editorial: Checkpoint inhibition in hematologic malignancies', Frontiers in Oncology, vol. 14, 1429854. https://doi.org/10.3389/fonc.2024.1429854
Hiller, A, Oxford, M, Kulkarni, P, Fornadley, J, Lo, A, Sivik, J, Drabick, J & Vakharia, K 2024, 'Efficacy of Cemiplimab as Adjuvant or Neoadjuvant Therapy in the Treatment of Cutaneous Squamous Cell Carcinoma', Annals of plastic surgery, vol. 92, no. 4, pp. S129-S131. https://doi.org/10.1097/SAP.0000000000003847
Vangala, V, Chen, YC, Dinavahi, SS, Gowda, K, Lone, NA, Herlyn, M, Drabick, J, Helm, K, Zhu, J, Neves, RI, Sharma, AK, Berg, A, Archetti, M, Amin, S, Schell, TD & Robertson, GP 2024, 'Tumor Heterogeneity Shapes Survival Dynamics in Drug-Treated Cells, Revealing Size-Drifting Subpopulations', ACS Pharmacology and Translational Science, vol. 7, no. 11, pp. 3573-3584. https://doi.org/10.1021/acsptsci.4c00453
2023
Joshi, M, Tuanquin, L, Zhu, J, Walter, V, Schell, T, Kaag, M, Kilari, D, Liao, J, Holder, SL, Emamekhoo, H, Sankin, A, Merrill, S, Zheng, H, Warrick, J, Hauke, R, Gartrel, B, Stein, M, Drabick, J, Degraff, DJ & Zakharia, Y 2023, 'Concurrent durvalumab and radiation therapy (DUART) followed by adjuvant durvalumab in patients with localized urothelial cancer of bladder: Results from phase II study, BTCRC-GU15-023', Journal for ImmunoTherapy of Cancer, vol. 11, no. 2, e006551. https://doi.org/10.1136/jitc-2022-006551
Lü, J, Jiang, C, Joshi, M & Drabick, JJ 2023, Giant Angelica: Angelica gigas Nakai – Herbal Giant’s Anticancer Potential. in Ancient and Traditional Foods, Plants, Herbs and Spices used in Cancer. CRC Press, pp. 165-180. https://doi.org/10.1201/9781003260028-15